Meropenem eq. to Anhydrous Meropenem 125mg Injection

Product Description: Meropenem eq. to Anhydrous Meropenem 125mg Dry Powder Injection is a broad-spectrum antibiotic belonging to the carbapenem class. It is used for the treatment of severe and complicated bacterial infections caused by multidrug-resistant organisms. Meropenem acts by inhibiting bacterial cell wall synthesis, making it highly effective against both Gram-positive and Gram-negative bacteria, including anaerobic strains. Each vial contains 125mg of Anhydrous Meropenem for parenteral use. MRP: ?225Packing: VialType: Dry Powder Injection Indications: Meropenem Injection is indicated for the treatment of: Lower respiratory tract infections (including pneumonia) Urinary tract infections (UTIs) Intra-abdominal infections Skin and soft tissue infections Gynecological infections Bacterial septicemia Meningitis and other severe infections caused by resistant bacteria Dosage & Administration: Adults: The usual dose is 500mg to 1g every 8 hours, depending on the type and severity of infection. Children (≥3 months): 10–20mg/kg body weight every 8 hours, or as prescribed by the physician. Route: Administer via intravenous (IV) injection or infusion only. Reconstitute the powder with sterile water for injection prior to administration. Dosage adjustment may be required in patients with renal impairment. Always use under the supervision of a registered medical practitioner. Storage: Store below 25°C, protected from moisture and direct sunlight. Keep out of reach of children. Use immediately after reconstitution. Disclaimer: This product information is provided for educational and informational purposes only and should not replace professional medical advice. Always consult a healthcare professional before using Meropenem 125mg Injection. Dosage and duration should be strictly followed as prescribed. Product details, MRP, and availability are subject to change according to regional guidelines and regulatory requirements.